Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 87806-31-3
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the clinical use of porfimer during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during porfimer therapy and for 5 months after the last dose.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Porfimer
CAS Registry Number
87806-31-3
Drug Class
Breast Feeding
Lactation
Milk, Human
Antineoplastic Agents
Dermatologic Agents
Photosensitizing Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Sodium Stibogluconate.[Drugs and Lactation Database (...]Review Sodium Stibogluconate.. Drugs and Lactation Database (LactMed®). 2006
- A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.[Lasers Surg Med. 2006]A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma.Oseroff AR, Blumenson LR, Wilson BD, Mang TS, Bellnier DA, Parsons JC, Frawley N, Cooper M, Zeitouni N, Dougherty TJ. Lasers Surg Med. 2006 Jun; 38(5):417-26.
- Review Sodium Chromate Cr 51.[Drugs and Lactation Database (...]Review Sodium Chromate Cr 51.. Drugs and Lactation Database (LactMed®). 2006
- Review [Porfimer sodium (Photofrin-II)].[Gan To Kagaku Ryoho. 1995]Review [Porfimer sodium (Photofrin-II)].Tsukagoshi S. Gan To Kagaku Ryoho. 1995 Aug; 22(9):1271-8.
- Evaluation of porfimer sodium fluorescence for measuring tissue transformation.[Cancer. 1993]Evaluation of porfimer sodium fluorescence for measuring tissue transformation.Crean DH, Liebow C, Penetrante RB, Mang TS. Cancer. 1993 Nov 15; 72(10):3068-77.
- Porfimer - Drugs and Lactation Database (LactMed®)Porfimer - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...